| Entry |
|
|---|
| Name |
Insulin peglispro (USAN/INN) |
|---|
| Formula |
C259H385N65O79S6 [C2H4O]n
|
|---|
| Class |
Antidiabetic agent
DG01636 Insulin preparation
DG01797 Insulin analog, long-acting
|
|---|
| Efficacy |
Antidiabetic, Insulin receptor agonist |
|---|
| Comment |
See Insulin lispro [DR: D04477]
Treatment of type 1 and type 2 diabetes
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG01636 Insulin preparation
DG01797 Insulin analog, long-acting
D10473 Insulin peglispro
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
INSR family
INSR (CD220)
D10473 Insulin peglispro (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
